- Home
- SNTI vs UGRO Comparison
SNTI vs UGRO Comparison
Compare SNTI & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- UGRO
- Stock Information
- Founded
- SNTI 2016
- UGRO 2014
- Country
- SNTI United States
- UGRO United States
- Employees
- SNTI N/A
- UGRO 130
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- UGRO Industrial Specialties
- Sector
- SNTI Health Care
- UGRO Consumer Discretionary
- Exchange
- SNTI Nasdaq
- UGRO Nasdaq
- Market Cap
- SNTI 14.1M
- UGRO 18.0M
- IPO Year
- SNTI N/A
- UGRO N/A
- Fundamental
- Price
- SNTI $2.21
- UGRO $1.46
- Analyst Decision
- SNTI
- UGRO Strong Buy
- Analyst Count
- SNTI 0
- UGRO 2
- Target Price
- SNTI N/A
- UGRO $5.63
- AVG Volume (30 Days)
- SNTI 20.4K
- UGRO 20.7K
- Earning Date
- SNTI 11-11-2024
- UGRO 11-07-2024
- Dividend Yield
- SNTI N/A
- UGRO N/A
- EPS Growth
- SNTI N/A
- UGRO N/A
- EPS
- SNTI N/A
- UGRO N/A
- Revenue
- SNTI $338,000.00
- UGRO $70,320,066.00
- Revenue This Year
- SNTI $254.47
- UGRO $14.76
- Revenue Next Year
- SNTI $169.66
- UGRO $21.29
- P/E Ratio
- SNTI N/A
- UGRO N/A
- Revenue Growth
- SNTI N/A
- UGRO 12.08
- 52 Week Low
- SNTI $1.52
- UGRO $1.02
- 52 Week High
- SNTI $8.48
- UGRO $2.84
- Technical
- Relative Strength Index (RSI)
- SNTI 38.51
- UGRO 56.59
- Support Level
- SNTI $2.05
- UGRO $1.34
- Resistance Level
- SNTI $2.48
- UGRO $1.55
- Average True Range (ATR)
- SNTI 0.25
- UGRO 0.10
- MACD
- SNTI -0.05
- UGRO 0.01
- Stochastic Oscillator
- SNTI 12.90
- UGRO 72.52
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.